Bavarian Nordic’s stock soared 10% on Thursday after the Danish biotech company posted better-than-expected second-quarter earnings and unveiled an order for 440,000 doses of smallpox and mpox ...

Freshfields has advised Permira and Nordic Capital on their all-cash, voluntary, and recommended public takeover offer for Bavarian Nordic.

Each private equity firm had a corporate adviser, while separate firms provided financing, competition and local counsel.

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consi ...

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its ...

A new study by WashU Medicine researchers found that, in mice, histamine-releasing immune cells act as gatekeepers that protect the brain from infection.

The vaccine maker’s board intends to recommend a pending offer from investment firms Nordic Capital and Permira, which would ...

The directors of the vaccine maker said the offer from Permira and Nordic Capital was an attractive proposal and recommended ...

A consortium led by Nordic Capital and Permira has made an offer of around $3 billion to buy all the shares of Bavarian Nordic , the vaccine maker said on Monday.

A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic, the ...

After what Bavarian Nordic described as “intense negotiations,” the Danish vaccine maker has agreed to be acquired by a private equity consortium in a 19 billion krone ($3 billion) deal ...

Investing.com -- Bavarian Nordic (CSE: BAVA) has agreed to a 19 billion Danish kroner ($2.99 billion) takeover offer from private-equity firms Permira and Nordic Capital. The Danish vaccine maker’s ...